These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 27904082)
1. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents. Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082 [TBL] [Abstract][Full Text] [Related]
2. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist. Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289 [TBL] [Abstract][Full Text] [Related]
3. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs]. Mel'nik OV; Martinovich VP; Golubovich VP Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp). Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494 [TBL] [Abstract][Full Text] [Related]
5. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity. Ozeki E; Matsuda T ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751 [TBL] [Abstract][Full Text] [Related]
6. Circular dichroism studies of type III collagen mimetic peptides with anti- or pro-aggregant activities on human platelets. Pêcher J; Pires V; Djaafri I; Da Nascimento S; Fauvel-Lafève F; Legrand C; Sonnet P Eur J Med Chem; 2009 Jun; 44(6):2643-50. PubMed ID: 19056149 [TBL] [Abstract][Full Text] [Related]
7. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure. Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663 [TBL] [Abstract][Full Text] [Related]
8. THE SEARCH OF COMPOUNDS WITH ANTIAGGREGATION ACTIVITY AMONG S-ESTERS OF THIOSULFONIC ACIDS. Halenova TI; Nikolaeva IV; Nakonechna AV; Bolibrukh KB; Monka NY; Lubenets VI; Savchuk OM; Novikov VP; Ostapchenko LI Ukr Biochem J; 2015; 87(5):83-92. PubMed ID: 26717599 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides. Dal Pozzo A; Fagnoni M; Bergonzi R; Vanini L; de Castiglione R; Aglio C; Colli S J Pept Res; 2000 Jun; 55(6):447-54. PubMed ID: 10888201 [TBL] [Abstract][Full Text] [Related]
11. [Antiaggregation activity of arachidonic acid conjugates with neurotropic peptides proglyprol and semax]. Bezuglov VV; Gretskaia NM; Vasil'eva TM; Petrukhina GN; Andreeva LA; Miasoedov NF; Makarov VA Eksp Klin Farmakol; 2014; 77(6):30-2. PubMed ID: 25102733 [TBL] [Abstract][Full Text] [Related]
12. Discovery of an orally active non-peptide fibrinogen receptor antagonist. Stilz HU; Jablonka B; Just M; Knolle J; Paulus EF; Zoller G J Med Chem; 1996 May; 39(11):2118-22. PubMed ID: 8667355 [No Abstract] [Full Text] [Related]
13. Design, synthesis and cardioprotective effect of a new class of dual-acting agents: phenolic tetrahydro-beta-carboline RGD peptidomimetic conjugates. Bi W; Cai J; Liu S; Baudy-Floc'h M; Bi L Bioorg Med Chem; 2007 Nov; 15(22):6909-19. PubMed ID: 17827017 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis and antiaggregative activity of a new RGDF mimetic]. Krys'ko AA; Malovichko OL; Kabanova TA; Mazepa AV Bioorg Khim; 2004; 30(6):594-8. PubMed ID: 15586810 [TBL] [Abstract][Full Text] [Related]
16. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships. Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides. Liu XJ; Shi XX; Zhong YL; Liu N; Liu K Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272 [TBL] [Abstract][Full Text] [Related]
18. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation. Swenson S; Bush LR; Markland FS Arch Biochem Biophys; 2000 Dec; 384(2):227-37. PubMed ID: 11368309 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724 [TBL] [Abstract][Full Text] [Related]